甘李药业：11月10日召开董事会会议

Group 1 - The core point of the article is that Ganli Pharmaceutical (SH 603087) held its fifth board meeting on November 10, 2025, to discuss new related parties and expected daily related transactions for 2025 and 2026 [1] - For the year 2024, Ganli Pharmaceutical's revenue composition is entirely from the pharmaceutical manufacturing industry, accounting for 100.0% [1] - As of the time of reporting, Ganli Pharmaceutical has a market capitalization of 38.6 billion yuan [1]